Inventor · Oakland, CA, US

Thomas Gadek

67Patents
20h-index
61Co-inventors
91Inventor score

Filing activity: Jun 21, 1976 → Nov 4, 2021

Most-cited inventions

PatentTitleAreaCited byStatus
US4897355A N[.omega.,(.omega.-1)-dialkyloxy]- and N-[.omega.,(.omega.-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor Emerging Cross-Sectional Technologies 670 Expired
US4946787A N-(.omega.,(.omega.-1)-dialkyloxy)- and N-(.omega.,(.omega.-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor Chemistry; Metallurgy 274 Expired
US5049386A N-.omega.,(.omega.-1)-dialkyloxy)- and N-(.omega.,(.omega.-1)-dialkenyloxy)Alk-1-YL-N,N,N-tetrasubstituted ammonium lipids and uses therefor Chemistry; Metallurgy 203 Expired
US5208036A N-(.omega., (.omega.-1)-dialkyloxy)- and N-(.omega., (.omega.-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor Emerging Cross-Sectional Technologies 186 Expired
US5545412A N-[1, (1-1)-dialkyloxy]-and N-[1, (1-1)-dialkenyloxy]-alk-1-yl-n,n,n-tetrasubstituted ammonium lipids and uses therefor Emerging Cross-Sectional Technologies 108 Expired
US8168655B2 Compositions and methods for treatment of eye disorders Physics 78 Active
US6005117A Imino compounds, process for their preparation and their use as victronectin antagonists Human Necessities 41 Expired
US5550289A N-(1,(1-1)-dialkyloxy)-and N-(1,(1-1)-dialkenyloxy alk-1-yl-N-N,N-tetrasubstituted ammonium lipids and uses therefor Emerging Cross-Sectional Technologies 37 Expired
US5493007A Platelet aggregation inhibitors having high specificity for GPIIBIIIA Emerging Cross-Sectional Technologies 35 Expired
US6667318B2 LFA-1 antagonist compounds Chemistry; Metallurgy 34 Expired
US8080562B2 Crystalline pharmaceutical and methods of preparation and use thereof Human Necessities 32 Active
US6340679B1 Guanidine derivatives as inhibitors of cell adhesion Chemistry; Metallurgy 30 Expired
US6872735B2 LFA-1 antagonist compounds Chemistry; Metallurgy 29 Expired
US8367701B2 Crystalline pharmaceutical and methods of preparation and use thereof Human Necessities 29 Active
US5565449A Nonpeptidyl integrin inhibitors having specificity for the GPII.sub.b III.sub.a receptor Chemistry; Metallurgy 27 Expired
US5403836A Benzazepine platelet aggregation inhibitors having specificity for the GPII.sub.b III.sub.a receptor Chemistry; Metallurgy 24 Expired
US8592450B2 Compositions and methods for treatment of eye disorders Physics 21 Active
US6387395B1 N-[1, (1-1) -dialkyloxy] - and N- [1, (1-1) -dialkenyloxy]- alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor Emerging Cross-Sectional Technologies 21 Expired
US9447077B2 Crystalline pharmaceutical and methods of preparation and use thereof Human Necessities 20 Active
US5366737A N-[.omega.,(.omega.-1)-dialkyloxy]- and N-[.omega.,(.omega.-1)-dialkenyloxy]-alk-1-yl-N,N,N,-tetrasubstituted ammonium lipids and uses therefor Emerging Cross-Sectional Technologies 20 Expired
US6660728B2 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists Chemistry; Metallurgy 19 Expired
US5250679A Nonpeptidyl platelet aggregation inhibitors having specificity for the GPII.sub.b III.sub. receptor Chemistry; Metallurgy 16 Expired
US6313119A Sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion Chemistry; Metallurgy 14 Expired
US6221907A Tricyclic compounds having activity specific for integrins, particularly alphanubeta3 integrins, method for preparing same, intermediates therefor, use of said compounds as drugs, and pharmaceutical compositions containing same Emerging Cross-Sectional Technologies 14 Expired
US6723727B1 Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them Human Necessities 12 Expired

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.